Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer (Q40317158)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2005

edit

Language	Label	Description	Also known as
English	Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer	scientific article published on January 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

title

Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

main subject

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Chang F Qu

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Emma Y Song

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Yong Li

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Syed M A Rizvi

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Chand Raja

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Ross Smith

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Alfred Morgenstern

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

C Apostolidis

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Barry J Allen

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

publication date

1 January 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

published in

Clinical & Experimental Metastasis

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

volume

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

page(s)

575-586

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

cites work

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10585-005-5788-9

retrieved

21 January 2018

Radioimmunotherapy with alpha-emitting nuclides

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapy of cancer with radiolabeled antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation induced apoptosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japan Pancreatic Cancer Registry: current status.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted alpha therapy for cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of suramin on metastatic ability, proliferation, and production of urokinase-type plasminogen activator and plasminogen activator inhibitor type 2 in human renal cell carcinoma cell line SN12C-PM6.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunotherapy with iodine (131)I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can alpha-immunotherapy succeed where other systemic modalities have failed?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted alpha particle immunotherapy for myeloid leukemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: the potential role of terbium-149

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological and clinical aspects of plasminogen activator inhibitor type 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: immunohistochemical study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The complexity of DNA damage: relevance to biological consequences

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Directed plasminogen activation at the surface of normal and malignant cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16475028

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10585-005-5788-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

Dimensions Publication ID

1026884090

0 references

PubMed publication ID

16475028

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16475028

retrieved

19 September 2017

ResearchGate publication ID

7301730

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40317158&oldid=2203597866"